Cargando…

Killer cell immunoglobulin-like receptor 3DL1 polymorphism defines distinct hierarchies of HLA class I recognition

Natural killer (NK) cells play a key role in immunity, but how HLA class I (HLA-I) and killer cell immunoglobulin-like receptor 3DL1 (KIR3DL1) polymorphism impacts disease outcome remains unclear. KIR3DL1 (*001/*005/*015) tetramers were screened for reactivity against a panel of HLA-I molecules. Thi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Saunders, Philippa M., Pymm, Phillip, Pietra, Gabriella, Hughes, Victoria A., Hitchen, Corinne, O’Connor, Geraldine M., Loiacono, Fabrizio, Widjaja, Jacqueline, Price, David A., Falco, Michela, Mingari, Maria Cristina, Moretta, Lorenzo, McVicar, Daniel W., Rossjohn, Jamie, Brooks, Andrew G., Vivian, Julian P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Rockefeller University Press 2016
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4854737/ https://www.ncbi.nlm.nih.gov/pubmed/27045007 http://dx.doi.org/10.1084/jem.20152023

Ejemplares similares

Structural plasticity of KIR2DL2 and KIR2DL3 enables altered docking geometries atop HLA-C
por: Moradi, Shoeib, et al.
Publicado: (2021)

Mutational and Structural Analysis of KIR3DL1 Reveals a Lineage-Defining Allotypic Dimorphism That Impacts Both HLA and Peptide Sensitivity
por: O’Connor, Geraldine M., et al.
Publicado: (2014)

Characterization of KIR (+) NK cell subsets with a monoclonal antibody selectively recognizing KIR2DL1 and blocking the specific interaction with HLA‐C
por: Meazza, Raffaella, et al.
Publicado: (2022)

Peptide-Dependent Recognition of HLA-B*57:01 by KIR3DS1
por: O'Connor, Geraldine M., et al.
Publicado: (2015)

Susceptibility of Human Melanoma Cells to Autologous Natural Killer (NK) Cell Killing: HLA-Related Effector Mechanisms and Role of Unlicensed NK Cells
por: Carrega, Paolo, et al.
Publicado: (2009)

The Emerging Role of HLA-E-Restricted CD8(+) T Lymphocytes in the Adaptive Immune Response to Pathogens and Tumors
por: Pietra, Gabriella, et al.
Publicado: (2010)

Natural killer cells: From surface receptors to the cure of high‐risk leukemia (Ceppellini Lecture)
por: Falco, Michela, et al.
Publicado: (2019)

The killer immunoglobulin-like receptor KIR3DL1 combination with HLA-Bw4 is protective against multiple sclerosis in African Americans
por: Hollenbach, Jill A., et al.
Publicado: (2016)

Killer Ig-Like Receptors (KIRs): Their Role in NK Cell Modulation and Developments Leading to Their Clinical Exploitation
por: Pende, Daniela, et al.
Publicado: (2019)

An Anti-inflammatory microRNA Signature Distinguishes Group 3 Innate Lymphoid Cells From Natural Killer Cells in Human Decidua
por: Pelosi, Andrea, et al.
Publicado: (2020)

Activation‐Induced Killer Cell Immunoglobulin‐like Receptor 3DL2 Binding to HLA–B27 Licenses Pathogenic T Cell Differentiation in Spondyloarthritis
por: Ridley, Anna, et al.
Publicado: (2016)

Inhibitory checkpoints in human natural killer cells: IUPHAR Review 28
por: Mariotti, F.R., et al.
Publicado: (2020)

Allele imputation for the killer cell immunoglobulin-like receptor KIR3DL1/S1
por: Harrison, Genelle F., et al.
Publicado: (2022)

Interaction of a dengue virus NS1‐derived peptide with the inhibitory receptor KIR3DL1 on natural killer cells
por: Townsley, E., et al.
Publicado: (2015)

ERAP1 Controls the Interaction of the Inhibitory Receptor KIR3DL1 With HLA-B51:01 by Affecting Natural Killer Cell Function
por: D’Amico, Silvia, et al.
Publicado: (2021)

Killer Immunoglobulin-Like Receptor 2DS2 (KIR2DS2), KIR2DL2-HLA-C1, and KIR2DL3 as Genetic Markers for Stratifying the Risk of Cytomegalovirus Infection in Kidney Transplant Recipients
por: Deborska-Materkowska, Dominika, et al.
Publicado: (2019)

New perspectives on the ligands and function of the killer cell immunoglobulin-like receptor KIR3DL2 in health and disease
por: Shaw, Jacqueline, et al.
Publicado: (2012)

Killer cell immunoglobulin-like receptor 2DL4 is expressed in and suppresses the cell growth of Langerhans cell histiocytosis
por: Takei, Yusuke, et al.
Publicado: (2017)

Influence of Interleukin IL-2 and IL-12 + IL-18 on Surface Expression of Immunoglobulin-Like Receptors KIR2DL1, KIR2DL2, and KIR3DL2 in Natural Killer Cells
por: Chrul, Slawomir, et al.
Publicado: (2006)

Dendritic Cell Editing by Activated Natural Killer Cells Results in a More Protective Cancer-Specific Immune Response
por: Morandi, Barbara, et al.
Publicado: (2012)

Quantitative Multiplex Real-Time Reverse Transcriptase–Polymerase Chain Reaction with Fluorescent Probe Detection of Killer Immunoglobulin-Like Receptors, KIR2DL4/3DL3
por: Wongfieng, Wipaporn, et al.
Publicado: (2020)

Hierarchy of resistance to cervical neoplasia mediated by combinations of killer immunoglobulin-like receptor and human leukocyte antigen loci
por: Carrington, Mary, et al.
Publicado: (2005)

How melanoma cells inactivate NK cells
por: Pietra, Gabriella, et al.
Publicado: (2012)

Killer Cell Immunoglobulin-like Receptors and Their HLA Ligands are Related with the Immunopathology of Chagas Disease
por: Ayo, Christiane Maria, et al.
Publicado: (2015)

NK Cells Expressing the Inhibitory Killer Immunoglobulin-Like Receptors (iKIR) KIR2DL1, KIR2DL3 and KIR3DL1 Are Less Likely to Be CD16+ than Their iKIR Negative Counterparts
por: Isitman, Gamze, et al.
Publicado: (2016)

Interaction between human leukocyte antigen (HLA-C) and killer cell Ig-like receptors (KIR2DL) inhibits the cytotoxicity of natural killer cells in patients with hepatoblastoma
por: Guo, Jing-Jie, et al.
Publicado: (2022)

Human NK Cells: From Surface Receptors to the Therapy of Leukemias and Solid Tumors
por: Moretta, Lorenzo, et al.
Publicado: (2014)

Diversity of Killer Cell Immunoglobulin-Like Receptor (KIR) Genotypes and KIR2DL2/3 Variants in HCV Treatment Outcome
por: Vidal-Castiñeira, Jose Ramón, et al.
Publicado: (2014)

Killer Immunoglobulin-like Receptor (KIR) and HLA Genotypes Affect the Outcome of Allogeneic Kidney Transplantation
por: Nowak, Izabela, et al.
Publicado: (2012)

HLA and killer cell immunoglobulin-like receptor (KIRs) genotyping in patients with acute viral encephalitis
por: Tuttolomondo, Antonino, et al.
Publicado: (2018)

HLA and killer cell immunoglobulin-like receptor (KIRs) genotyping in patients with acute ischemic stroke
por: Tuttolomondo, Antonino, et al.
Publicado: (2019)

Paternal HLA-C and Maternal Killer-Cell Immunoglobulin-Like Receptor Genotypes in the Development of Autism
por: Gamliel, Moriya, et al.
Publicado: (2016)

Analysis of Killer Cell Immunoglobulin-Like Receptor Genes and Their HLA Ligands in Inflammatory Bowel Diseases
por: Beigmohammadi, Fereshteh, et al.
Publicado: (2020)

Killer cell immunoglobulin-like receptor (KIR) genes and their HLA ligands in a Brazilian population
por: Cardozo, Daniela Maira, et al.
Publicado: (2023)

Stable Frequencies of HLA-C(*)03:04/Peptide-Binding KIR2DL2/3(+) Natural Killer Cells Following Vaccination
por: Ziegler, Maja Christiane, et al.
Publicado: (2018)

HLA-Bw4 in association with KIR3DL1 favors natural killer cell-mediated protection against severe COVID-19
por: Wang, Ruihua, et al.
Publicado: (2023)

Cellular and molecular basis of haploidentical hematopoietic stem cell transplantation in the successful treatment of high-risk leukemias: role of alloreactive NK cells
por: Locatelli, Franco, et al.
Publicado: (2013)

HLA-B*27:05 alters immunodominance hierarchy of universal influenza-specific CD8(+) T cells
por: Sant, Sneha, et al.
Publicado: (2020)

Epitope characterization of a monoclonal antibody that selectively recognizes KIR2DL1 allotypes
por: Falco, Michela, et al.
Publicado: (2022)

Distribution of killer cell immunoglobulin-like receptors (KIR) and their HLA-C ligands in two Iranian populations
por: Hiby, Susan E., et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_nqfhpvcdm42ojk5nuh6pd7op4m